What Is the Current Status of Research and Clinical Trials?
Numerous clinical trials are underway to evaluate the efficacy and safety of nanoparticle-based treatments. Some therapies have already received FDA approval and are being used clinically, such as liposomal formulations of doxorubicin. Research continues to improve the targeting accuracy, reduce toxicity, and explore new types of nanoparticles.
